ACE2 and infection: Specific inhibitory antibodies produced by natural infection or vaccine can bind to the spike protein, blocking the formation of the SARS-CoV-2-RBD-human angiotensin-converting enzyme 2 (hACE2) complex and cutting off the main route of infection.